Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

This article is part of the supplement: B cells in autoimmune diseases: Part 2

Review

B-cell depletion in SLE: clinical and trial experience with rituximab and ocrelizumab and implications for study design

Venkat Reddy*, David Jayne, David Close and David Isenberg

Arthritis Research & Therapy 2013, 15(Suppl 1):S2  doi:10.1186/ar3910

Article Metrics

4217
Total accesses

Article metric FAQ

Accesses  

  • Last 30 days: 296 accesses
  • Last 365 days: 2370 accesses
  • All time: 4217 accesses

These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information